hero section gradient
14 handpicked stocks

Synthetic-Bio Foundries

Discover companies that are programming living cells to create the materials of tomorrow. These carefully selected stocks represent pioneers in replacing petrochemical processes with cleaner, more efficient biological alternatives - essentially turning microbes into tiny manufacturing plants.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Concise market-cap summary and investor takeaways for the Synthetic-Bio Foundries stock basket.

Key Takeaways for Investors:
  • Large-cap dominance suggests generally lower volatility and closer tracking to broad market movements than small-cap baskets.
  • Best used as a core, long-term holding rather than a speculative, high-growth allocation.
  • Expect steady, long-term appreciation rather than explosive short-term gains; growth is more measured.
Total Market Cap
  • DNA: $737.90M

  • TWST: $2.02B

  • CDXS: $249.14M

  • Other

About This Group of Stocks

1

Our Expert Thinking

Synthetic biology represents a manufacturing revolution where engineered microorganisms replace industrial chemistry. These companies are creating cellular factories that can produce everything from fragrances to fuels more sustainably. This group captures both the foundry platforms and the essential tools enabling this bio-industrial transformation.

2

What You Need to Know

This collection spans diverse sectors including gene editing, DNA synthesis, enzyme development, and biofuel production. Consider it a high-growth satellite position that offers exposure to the convergence of biology, technology and manufacturing. The integration of AI is accelerating development timelines across the entire sector.

3

Why These Stocks

We've selected companies with scalable technology platforms, strong intellectual property, and clear commercialization paths. Our picks include both the "foundries" themselves and the "picks and shovels" companies that provide essential tools like DNA synthesis and sequencing technology that make this new form of manufacturing possible.

Why You'll Want to Watch These Stocks

🧬

Biology's Industrial Revolution

These companies aren't just creating products - they're reinventing how things are made. By programming cells instead of chemicals, they're pioneering manufacturing methods that could make traditional factories obsolete.

🤖

AI Is Supercharging Development

Artificial intelligence is dramatically accelerating what these bio-foundries can achieve. Companies integrating AI into their platforms are compressing years of research into months, potentially leapfrogging competitors.

🌱

The Sustainable Manufacturing Shift

As corporations face pressure to reduce environmental impact, these bio-alternatives are becoming increasingly attractive. These stocks represent the companies building cleaner production methods that major industries will need to adopt.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Streaming Power Dynamics Explained | Content Wars

Streaming Power Dynamics Explained | Content Wars

The resolution of the content dispute between Disney and Google's YouTube TV highlights the critical interdependence of content creators and distributors. This dynamic creates an investment opportunity in companies that are central to the streaming ecosystem, from content production to platform delivery.

Jeep Hybrid Recall Overview: Market Shift Analysis

Jeep Hybrid Recall Overview: Market Shift Analysis

Stellantis is recalling nearly 113,000 Jeep plug-in hybrids because of a serious engine defect, creating potential investment opportunities. This theme focuses on competing automakers and aftermarket parts suppliers that may benefit from a shift in consumer confidence and repair needs.

Frequently Asked Questions